Episodes (Page 2)
When board turns, but mission stays | Armon Sharei, Founder & CEO at Portal on Resilience in Biotech
✨
Episode: When board turns, but mission stays | Armon Sharei, Founder & CEO at Portal on Resilience in Biotech
Armon Sharei
✨
Episode: The 10% mindset and power of bold ideas | Prof. Dr. Dominik Ruettinger, Global Head Oncology R&D, Bayer Pharmaceuticals
Global Head Oncology R
Prof. Dominik Ruettinger
✨
Episode: Startups are hard, do something that matters | Armand Cognetta, CEO & founder General Proximity
Armand Cognetta
founder General Proximity
✨
Dr. William Pao discusses leading cancer research and Revelio Therapeutics.
✨
Dr. Peter Campbell discusses turning genomic insights into therapies.
✨
Raj Devraj shares his journey from India to biotech leadership.
Raj Devraj
✨
Episode: The unsolved frontier: making the undruggable druggable | Eswar Iyer, Aikium
Eswar Iyer
✨
Episode: Reinventing R&D: collaboration for tomorrow’s therapies | Dr. Uli Stilz, BIH at Novo Nordisk
Uli Stilz
✨
Shelby Newsad transitioned from pre-med to biotech investing.
Shelby Newsad
✨
Dave Messina moved from computational biology to VC.
Dave Messina
✨
Episode: Empowering Future Biotech Leaders | Dr. Michelle Hoffmann, CBC
✨
Dr. Stehman-Breen discusses her career in medicine and pharma.
Epigenetic Editing
✨
Episode: Revolutionizing Gene Therapy with AI | Eric Kelsic, Dyno Tx
✨
Episode: From Sequencing the Human Genome to Venture Capital | Peter Barrett, Atlas Venture
✨
Episode: Designing Programmable Genetic Medicines | Jake Becraft, Strand Therapeutics
Jake Becraft
✨
Dr. Marina Gerner discusses her book, 'The Vagina Business'.
✨
Michael Langer blends biotech, VC, and filmmaking.
✨
Leo Grady founded Jona to analyze the gut microbiome with AI.
✨
Luke Timmerman is a biotech journalist and podcast host.
✨
Irene Blat seeks oncology therapies for Servier.
Irene Blat